MAPT and Alzheimer disease: With the development of novel cell-based detection systems (termed "biosensors") the Diamond lab subsequently determined that tau-mediated seeding activity correlates with disease progression and anticipates classical pathological markers in mouse models of tauopathy and in Alzheimer’s disease [40, 53, 54, 68].